Initiator Pharma A/S
STO:INIT

Watchlist Manager

Initiator Pharma A/S

STO:INIT

Watchlist

Dividends

Discount Rate

Price: 7.1 SEK 2.9% Market Closed

Market Cap: 375.7m SEK

Have any thoughts about
Initiator Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 7.1 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

INIT Alert

Initiator Pharma A/S

7.1

+0.2 (+2.9%)

52 Week Range	6.55 10.4
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Initiator Pharma A/S

What unique competitive advantages
does Initiator Pharma A/S hold over its rivals?

What risks and challenges
does Initiator Pharma A/S face in the near future?

Provide an overview of the primary business activities
of Initiator Pharma A/S.

Show me price targets
for Initiator Pharma A/S made by professional analysts.

Provide an overview of the primary business activities
of Initiator Pharma A/S.

What unique competitive advantages
does Initiator Pharma A/S hold over its rivals?

What risks and challenges
does Initiator Pharma A/S face in the near future?

Show all valuation multiples
for Initiator Pharma A/S.

Provide P/S
for Initiator Pharma A/S.

Provide P/E
for Initiator Pharma A/S.

Provide P/OCF
for Initiator Pharma A/S.

Provide P/FCFE
for Initiator Pharma A/S.

Provide P/B
for Initiator Pharma A/S.

Provide EV/S
for Initiator Pharma A/S.

Provide EV/GP
for Initiator Pharma A/S.

Provide EV/EBITDA
for Initiator Pharma A/S.

Provide EV/EBIT
for Initiator Pharma A/S.

Provide EV/OCF
for Initiator Pharma A/S.

Provide EV/FCFF
for Initiator Pharma A/S.

Provide EV/IC
for Initiator Pharma A/S.

Show me price targets
for Initiator Pharma A/S made by professional analysts.

What are the Revenue projections
for Initiator Pharma A/S?

How accurate were the past Revenue estimates
for Initiator Pharma A/S?

What are the Net Income projections
for Initiator Pharma A/S?

How accurate were the past Net Income estimates
for Initiator Pharma A/S?

What are the EPS projections
for Initiator Pharma A/S?

How accurate were the past EPS estimates
for Initiator Pharma A/S?

What are the EBIT projections
for Initiator Pharma A/S?

How accurate were the past EBIT estimates
for Initiator Pharma A/S?

Compare the revenue forecasts
for Initiator Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Initiator Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Initiator Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Initiator Pharma A/S compared to its peers.

Compare the P/E ratios
of Initiator Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Initiator Pharma A/S with its peers.

Analyze the financial leverage
of Initiator Pharma A/S compared to its main competitors.

Show all profitability ratios
for Initiator Pharma A/S.

Provide ROE
for Initiator Pharma A/S.

Provide ROA
for Initiator Pharma A/S.

Provide ROIC
for Initiator Pharma A/S.

Provide ROCE
for Initiator Pharma A/S.

Provide Gross Margin
for Initiator Pharma A/S.

Provide Operating Margin
for Initiator Pharma A/S.

Provide Net Margin
for Initiator Pharma A/S.

Provide FCF Margin
for Initiator Pharma A/S.

Show all solvency ratios
for Initiator Pharma A/S.

Provide D/E Ratio
for Initiator Pharma A/S.

Provide D/A Ratio
for Initiator Pharma A/S.

Provide Interest Coverage Ratio
for Initiator Pharma A/S.

Provide Altman Z-Score Ratio
for Initiator Pharma A/S.

Provide Quick Ratio
for Initiator Pharma A/S.

Provide Current Ratio
for Initiator Pharma A/S.

Provide Cash Ratio
for Initiator Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Initiator Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Initiator Pharma A/S?

What is the current Free Cash Flow
of Initiator Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Initiator Pharma A/S.

EV/EBIT
Enterprise Value to EBIT

-13.4

Current

-9.7

Median

3.8

Industry

Lower than median

Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT

-13.4

Enterprise Value

375.4m SEK

EBIT

-18m DKK

All Countries

Forward Multiples

			Market Cap	EV/EBIT
DK	I	Initiator Pharma A/S STO:INIT	398m SEK	-13.4
FR		Pharnext SCA OTC:PNEXF	6T USD	-214 322.8
US		Abbvie Inc NYSE:ABBV	301B USD	22.8
US		Amgen Inc NASDAQ:AMGN	162B USD	33.7
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	127.5B USD	28.2
US		Gilead Sciences Inc NASDAQ:GILD	115.4B USD	10.2
US	E	Epizyme Inc F:EPE	94.1B EUR	-507.3
AU		CSL Ltd ASX:CSL	138B AUD	26
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	88.6B USD	19.4
US	S	Seagen Inc F:SGT	39.3B EUR	-53.7
NL		argenx SE XBRU:ARGX	34.1B EUR	-76.1

				EBIT Growth
DK	I	Initiator Pharma A/S STO:INIT	Average EV/EBIT: 23.4 Negative Multiple: -13.4	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -214 322.8	N/A
US		Abbvie Inc NYSE:ABBV	22.8	88%
US		Amgen Inc NASDAQ:AMGN	33.7	93%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	28.2	44%
US		Gilead Sciences Inc NASDAQ:GILD	10.2	29%
US	E	Epizyme Inc F:EPE	Negative Multiple: -507.3	N/A
AU		CSL Ltd ASX:CSL	26	55%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	19.4	54%
US	S	Seagen Inc F:SGT	Negative Multiple: -53.7	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -76.1	N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBIT

4.6

2-Years Forward

EV/EBIT

-9.7

3-Years Forward

EV/EBIT

-19.7

Initiator Pharma A/S
STO:INIT

EV/EBIT
Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

Initiator Pharma A/S STO:INIT

EV/EBIT Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

Initiator Pharma A/S
STO:INIT

EV/EBIT
Enterprise Value to EBIT